Evidence map›Paper›PMID 18194817›Full record

ArticleImmunology letters2008

MHC class II structural requirements for the association with Igalpha/beta, and signaling of calcium mobilization and cell death.

Lei Jin, John C Stolpa, Ryan M Young, Aimee E Pugh-Bernard, Yosef Refaeli, John C Cambier

Open access · greenAbstract read
In one paragraph

Article in Immunology letters, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lei JinDepartment of Immunology, University of Colorado at Denver and Health Sciences Center and National Jewish Medical and Research Center, Denver, CO 80206, United States.
John C Stolpa
Ryan M Young
Aimee E Pugh-Bernard
Yosef Refaeli
John C Cambier
University of Colorado Denver · USNational Jewish Health · US

Funding

MOLECULAR BIOLOGY OF B CELL TOLERANCE AND ACTIVATIONR01AI020519 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C. · 1985 to 2007
$2.3M
MYC-induced breach of B-cell anergy in AIDS-related NHLsR01CA117802 · NCI · UNIVERSITY OF COLORADO DENVER · PI REFAELI, YOSEF · 2006 to 2010
$1.5M
NCI NIH HHS R01 CA117802NCI NIH HHS R01CA117802NIAID NIH HHS 5R01AI020519-22NIAID NIH HHS R01 AI020519
6 · The paper itself

Abstract

Emerging evidence indicates that in addition to their well-characterized role in antigen presentation, MHC II molecules transmit signals that induce death of APCs. Appropriately timed APC death is important for prevention of autoimmunity. Though the exact mechanism of MHC II-mediated cell death signaling is unknown, the response appears independent of caspase activation and does not involve Fas-FasL interaction. Here we investigated MHC II structural requirements for mediation of cell death signaling in a murine B cell lymphoma. We found that neither the transmembrane spanning regions nor the cytoplasmic tails of MHC II, which are required for MHC II-mediated cAMP production and PKC activation, are required for the death response. However, mutations in the connecting peptide region of MHC II alpha chain (alphaCP), but not the beta chain (betaCP), resulted in significant impairment of the death response. The alphaCP mutant was also unable to mediate calcium mobilization responses, and did not associate with Igalpha/beta. Knock-down of Igbeta by shRNA eliminated the MHC II-mediated calcium response but not cell death. We propose that MHC II mediates cell death signaling via association with an undefined cell surface protein(s), whose interaction is partially dependent on alphaCP region.

Indexed as

Calcium SignalingAmino Acid SequenceAnimalsAntibodies, MonoclonalCalciumCD79 AntigensCell DeathCell Line, TumorHistocompatibility Antigens Class IIMiceMolecular Sequence DataAntibodies, MonoclonalCalciumCD79 AntigensCd79a protein, mouseCd79b protein, mouseHistocompatibility Antigens Class II

Identifiers

PMID18194817
PMCPMC2424217
OpenAlexW1979256282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.